Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 16, 2024 07:30 ET | Source: CVRx, Inc.

CVRx Announces Key Senior Leadership Team Hires

Dr. Philip B. Adamson will join as Chief Medical OfficerBonnie Handke will join as Senior Vice President of Patient Access, Reimbursement, and Healthcare EconomicsJennifer E. Englund joins as Senior...
April 30, 2024 16:05 ET | Source: CVRx, Inc.

CVRx Reports First Quarter 2024 Financial and Operating Results

MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
April 16, 2024 16:30 ET | Source: CVRx, Inc.

CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024

MINNEAPOLIS, April 16, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an...
April 15, 2024 07:30 ET | Source: CVRx, Inc.

CVRx announces availability of additional data supporting long-term benefits of Barostim

BeAT-HF trial data published in the European Journal of Heart Failure and new abstracts presented at THT conference MINNEAPOLIS, Minn., April 15, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX)...
January 31, 2024 08:00 ET | Source: CVRx, Inc.

CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer

Appointment effective February 12 following Nadim Yared’s retirement Hykes currently serves as Augmedics’ President and CEO, and has served on CVRx’s Board of Directors since 2022 MINNEAPOLIS, Jan. ...
January 25, 2024 16:05 ET | Source: CVRx, Inc.

CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

MINNEAPOLIS, Jan. 25, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
January 11, 2024 16:30 ET | Source: CVRx, Inc.

CVRx to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call on January 25th, 2024

MINNEAPOLIS, Jan. 11, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an...
January 08, 2024 08:30 ET | Source: CVRx, Inc.

CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results and Announces Nadim Yared Retirement Plans

Fourth quarter revenue expected to be $11.2 million to $11.3 million, representing growth of 56% to 58%Full year revenue expected to be $39.2 million to $39.3 million, representing growth of 74% to...
December 27, 2023 16:30 ET | Source: CVRx, Inc.

CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference

MINNEAPOLIS, Dec. 27, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
December 26, 2023 08:05 ET | Source: CVRx, Inc.

CVRx receives FDA approval for expanded labeling of Barostim

MINNEAPOLIS, Dec. 26, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the U.S. Food and Drug Administration (FDA) has...